Adma Biologics (ADMA) P/E (2013 - 2026)
Adma Biologics (ADMA) P/E from Oct 17, 2013 to Jul 21, 2026. The TTM Adma Biologics (ADMA) P/E is 12.29. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Adma Biologics (ADMA)
| Year | P/E | Change |
|---|---|---|
| 2026 | 12.29 | -58.46% |
| 2025 | 29.58 | +44.75% |
| 2024 | 20.43 | -146.42% |
| 2023 | -44.02 | +306.39% |
| 2022 | -10.83 | +288.60% |
| 2021 | -2.79 | +18.71% |
| 2020 | -2.35 | -48.60% |
| 2019 | -4.57 | +190.41% |
| 2018 | -1.57 | +11.30% |
| 2017 | -1.41 | -54.17% |
| 2016 | -3.08 | -35.88% |
| 2015 | -4.81 | -22.15% |
| 2014 | -6.18 | +86.17% |
| 2013 | -3.32 | N/A |
Comparison Adma Biologics (ADMA) P/E with competitors
Adma Biologics (ADMA) P/E is 12.29.